Trust Co. of Toledo NA OH Decreases Stock Holdings in Danaher Corporation $DHR

Trust Co. of Toledo NA OH decreased its holdings in shares of Danaher Corporation (NYSE:DHR) by 17.3% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 29,039 shares of the conglomerate’s stock after selling 6,062 shares during the quarter. Trust Co. of Toledo NA OH’s holdings in Danaher were worth $5,736,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in DHR. GAMMA Investing LLC raised its stake in shares of Danaher by 22.2% in the first quarter. GAMMA Investing LLC now owns 9,126 shares of the conglomerate’s stock valued at $1,871,000 after acquiring an additional 1,660 shares during the period. Assenagon Asset Management S.A. grew its holdings in Danaher by 1.0% during the 1st quarter. Assenagon Asset Management S.A. now owns 20,634 shares of the conglomerate’s stock worth $4,230,000 after acquiring an additional 203 shares in the last quarter. CX Institutional grew its holdings in Danaher by 11.2% during the 1st quarter. CX Institutional now owns 3,304 shares of the conglomerate’s stock worth $677,000 after acquiring an additional 334 shares in the last quarter. Zhang Financial LLC boosted its holdings in shares of Danaher by 3.6% in the 1st quarter. Zhang Financial LLC now owns 1,774 shares of the conglomerate’s stock valued at $364,000 after buying an additional 62 shares in the last quarter. Finally, Baker Chad R boosted its holdings in shares of Danaher by 7.1% in the 1st quarter. Baker Chad R now owns 68,665 shares of the conglomerate’s stock valued at $14,076,000 after buying an additional 4,545 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently weighed in on DHR. Royal Bank Of Canada set a $241.00 price target on shares of Danaher in a report on Tuesday, September 2nd. Guggenheim reissued a “buy” rating and set a $250.00 price target on shares of Danaher in a research report on Wednesday, July 23rd. Redburn Partners set a $220.00 target price on shares of Danaher in a report on Wednesday. UBS Group cut their target price on shares of Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a report on Wednesday, July 23rd. Finally, Rothschild Redb lowered shares of Danaher from a “strong-buy” rating to a “hold” rating in a report on Wednesday. Seventeen research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, Danaher has an average rating of “Moderate Buy” and a consensus price target of $244.60.

Insider Buying and Selling

In other news, Director Teri List sold 2,778 shares of the stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 11.10% of the stock is owned by insiders.

Danaher Trading Down 1.0%

Shares of DHR stock opened at $202.53 on Friday. The company’s 50-day moving average price is $200.66 and its 200-day moving average price is $197.25. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The stock has a market cap of $145.02 billion, a price-to-earnings ratio of 43.09, a PEG ratio of 2.91 and a beta of 0.77. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $279.41.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $5.94 billion for the quarter, compared to analysts’ expectations of $5.83 billion. During the same quarter in the previous year, the company posted $1.72 EPS. The company’s revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s dividend payout ratio is presently 27.23%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.